Young-A Lee

Dr. Young-A Lee


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2013 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
JKJu‐Yeon Kim
Ju‐Yeon Kim
YLYoung-A Lee
Young-A Lee
Christoph WittmannChristoph Wittmann
Christoph Wittmann
JPJin-Byung Park
Jin-Byung Park

1 January 2013 in Transplantation Proceedings
Verified
Journal Article
Closed access
HJHae Woon Jung
Hae Woon Jung
HKHye Young Kim
Hye Young Kim
YLYoung-A Lee
Young-A Lee
HKHee Gyung Kang
Hee Gyung Kang
CSC.H. Shin
C.H. Shin
SYS.W. Yang
S.W. Yang

1 July 2021 in Behavioural Brain Research
Verified
Journal Article
Closed access
YLYoung-A Lee
Young-A Lee
YKYu-Jeong Kim
Yu-Jeong Kim
JLJu Sung Lee
Ju Sung Lee
SLSanghyun Lee
Sanghyun Lee
YGYukiori Goto
Yukiori Goto

1 February 2018 in Behavioural Pharmacology
Verified
Journal Article
Closed access
YKYu-Jeong Kim
Yu-Jeong Kim
YGYukiori Goto
Yukiori Goto
YLYoung-A Lee
Young-A Lee
A partial agonist and a full antagonist of the histamine H3 receptor have been suggested to have therapeutic effects on cognitive deficits in psychiatric disorders. We have previously shown that neonatal habenula lesion (NHL) induces behavioral deficits that resemble the symptoms of attention deficit/hyperactivity disorder (ADHD). In this study, we examined the effects of three H3 antagonists on ADHD-like behavioral changes caused by NHL in rats. Behavioral tests and administration of the H3 receptor antagonists were performed in juvenile rats with NHL. H3 antagonist administration to juvenile rats dose dependently improved NHL-induced hyperlocomotion, impulsive behavior, and attention deficit. These results suggest that histamine H3 antagonists may be used as alternative therapeutic drugs for the treatment of ADHD.

19 May 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
WCWon-Hui Choe
Won-Hui Choe
KLKyung-A Lee
Kyung-A Lee
YGYukiori Goto
Yukiori Goto
YLYoung-A Lee
Young-A Lee
Our daily diet in the modern society has substantially changed from that in the ancient past. Consequently, new disorders associated with such dietary changes have emerged. For instance, excessive intake of compounds, such as sucrose (SUC), has recently been reported to induce pathological neuronal changes in adults, such as food addiction. It is still largely unclear whether and how excessive intake of such nutrients affects neurodevelopment. We investigated changes in behavior and monoamine signaling caused by excessive, semi-chronic intake of SUC and the non-caloric sweetener saccharin (SAC) in juvenile mice, using a battery of behavioral tests and high-performance liquid chromatography. Both SUC and SAC intake induced behavioral alterations such as altered amphetamine responses, sucrose preference, stress response, and anxiety, but did not affect social behavior and cognitive function such as attention in juvenile and adult mice. Moreover, SUC and SAC also altered dopamine and serotonin transmission in mesocorticolimbic regions. Some of these behavioral and neural alterations were triggered by SAC and SUC but others were distinct between the treatments. Moreover, alterations induced in juvenile mice were also different from those observed in adult mice. These results suggest that excessive SUC and SAC intake during the juvenile period may cause concurrent and delayed behavioral and monoamine signaling alterations in juvenile and adult mice, respectively.

21 January 2021 in Behavioural Pharmacology
Verified
Journal Article
Closed access
YKYe-Jin Kim
Ye-Jin Kim
SJSo-Yeon Jeon
So-Yeon Jeon
JCJae-Sue Choi
Jae-Sue Choi
NKNa-Hyun Kim
Na-Hyun Kim
YGYukiori Goto
Yukiori Goto
YLYoung-A Lee
Young-A Lee
Alterations of monoamine transmission in mesocorticolimbic regions have been suggested in the pathophysiology of attention deficit/hyperactivity disorder (ADHD). The habenula is an important brain area in regulation of monoamine transmission. In this study, we investigated behavioral and electrophysiological alterations induced by neonatal habenula lesion (NHL) in rats. In NHL rats, age-dependent behavioral alterations relevant to the ADHD symptoms, such as hyperlocomotion, impulsivity, and attention deficit, were observed. Local field potentials (LFPs) in mesocorticolimbic regions of anesthetized rats were examined with in vivo electrophysiological recordings. Abnormally enhanced synchronization of slow (delta) and fast (gamma) LFP oscillations between the amygdala (AMY) and prefrontal cortex (PFC) was found in juvenile, but not in adult, NHL rats. We further examined the effects of an extract and the active compound from the perennial large brown algae Ecklonia stolonifera (ES), which have previously been demonstrated to modulate monoamine transmission, on these NHL-induced alterations. One week of ES extract treatments normalized the NHL-induced behavioral alterations, whereas the active compound fucosterol improved attention deficit and impulsivity, but not hyperlocomotion, in NHL rats. Consistent with the behavioral effects, ES extract treatments also normalized augmented AMY-PFC coupling. These results suggest that altered limbic-cortical information processing may be involved in ADHD-like behavioral alterations induced by NHL, which could be ameliorated by the natural substance, such as ES that affects monoamine transmission.